QA: Tenax Therapeutics INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2020_Tenax_Therapeutics_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0000034956, Tenax Therapeutics INC

  xvar xval
0 AssetsCurrent 6,180,829
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 6,559
3 remainder_Assets 177,883
4 LiabilitiesCurrent 2,532,395
5 LiabilitiesNoncurrent 60,379
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,167,927
9 ResearchAndDevelopmentExpense 2,839,586
10 remainder_Expenses 3,206,095
11 remainder_Revenues 0
12 remainder_NetIncome 147,825
13 remainder_ComprehensiveNetIncome 20,602,911
  yvar yval
0 Assets 6,365,271
1 Liabilities 2,592,774
2 Expenses 11,213,608
3 Revenues 0
4 StockholdersEquity 3,772,497
5 NetIncome -11,065,783
6 ComprehensiveNetIncome -764,328
7 BaseVar 20,461,194
8 EconomicCapitalRatiobeforeLimitedLiability 1.67
9 EconomicCapitalRatio 2.80

Edgar->Model Mapping

Feature Distribution

Change over Time